Home > Insider Trading > Filing (0001209191-15-075196)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557746	Aclaris Therapeutics Inc.	ACRS	Pharmaceutical Preparations (2834)	460571712

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	Sofinnova Ventures, 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1245624	James Healy	Sofinnova Ventures, 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1253170	Srinivas Akkaraju	Sofinnova Ventures, 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1524064	Sofinnova Venture Partners Viii, L.p.	Sofinnova Ventures, 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No
1559565	Sofinnova Management Viii, L.l.c.	Sofinnova Ventures, 3000 Sand Hill Road, 4-250 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-10-13	1,880,390	$0.00	1,880,390	No	4	C	Direct
Common Stock	Acquisiton	2015-10-13	409,090	$11.00	2,289,480	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2015-10-13	2,000,000	$0.00	579,710	$0.00
Common Stock	Series B Preferred Stock	Disposition	2015-10-13	2,424,242	$0.00	702,678	$0.00
Common Stock	Series C Preferred Stock	Disposition	2015-10-13	2,063,107	$0.00	598,002	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	C	Direct

Footnotes

The total represents shares received upon conversion of shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock.
Effective upon the closing of the issuer's initial public offering of its common stock, each share of preferred stock automatically converted into 0.289855 shares of common stock. The preferred stock had no expiration date.
The shares are held of record by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual managing members of SVP VIII are Michael Powell, James Healy, Srinivas Akkaraju and Anand Mehra, and they may be deemed to share voting and dispositive power over the shares held by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares held by SVP VIII except to the extent of any pecuniary interest therein.